Intellia Q3 earnings: Worst performance as March 2027 decision looms

Intellia Q3 earnings reveal a quiet period as all eyes turn to the crucial March 2027 approval decision.

Retail price of drugs: Proven ways to save on medications

Retail price of drugs is crucial for consumers seeking affordable medication options.

BHVN Stock Price: The Best Quick Insights You Need

BHVN stock price insights provide a clear view of market trends and news affecting Biohaven Pharmaceutical.

Citi Pharma Acquisition Approval: Is It the Best Move?

Citi Pharma acquisition approval has been granted, raising questions about its impact on the pharmaceutical industry.

Cancer Drug Price Caps: Are They the Best Solution?

Cancer drug price caps are set to reduce costs by up to 70%.

Are Cancer Drug Prices Falling 70%? The Real Impact

Cancer drug prices are set to fall significantly, with a reduction of up to 70% starting Nov 9.

Cancer Drug Prices: Best Proven Strategy for Affordability

Cancer drug prices may drop significantly as the government caps profit margins at 30%.

Adapalene Gel Pump Packs: Best New Launch in US Market

Adapalene Gel Pump Packs are now available in the US, targeting the OTC market.

Symbiotec Pharmalab share price: Best Proven Growth Today

Symbiotec Pharmalab share price is up today due to a major US deal, reaching a 52-week high. Discover the factors behind this surge.

Aumolertinib Approval Revoked: What You Need to Know

Aumolertinib approval revoked due to data protection breach. Discover the implications for patients and the pharmaceutical industry.